NCI offers scientific models, reagents, data sets, and other R&D resources to the research community, as part of our ongoing commitment to cancer investigators to enable and expedite their research.
An online listing of approved and investigational targeted agents that can be tested in new preclinical or clinical studies, including combination studies of formulary agents from pharmaceutical and biotechnology company partners.
Links to data collections produced by major NCI initiatives and other widely used data sets.
Selected list of research tools, datasets, and methodologies related to behavioral research from the Division of Cancer Control and Population Science.
Find malignant, benign, diseased and normal biospecimens through NCI-funded resources.
Information and tools for investigators and research teams who are already involved in clinical trials, as well as for those who are thinking about getting involved.
Tools for study design and planning, analysis, and risk assessment, as well as publicly available data sets from the Division of Cancer Epidemiology and Genetics.
Services for intramural and extramural and industry researchers including RAS reagents and animal and genotyping services.
Find information about the National Cryo-EM Facility at NCI, created to provide researchers access to the latest cryo-EM technology for high resolution imaging. Includes timeline for installation, how to access the facility, and facility leadership.
Funding and technology transfer to small businesses for early-stage research and development in biomarkers, anti-cancer agents, medical devices, and other biotechnologies.
NCI's Surveillance, Epidemiology, and End Results (SEER) cancer databases, statistical methods, and software tools.
Partnership opportunities to commercialize inventions and technologies developed by NCI researchers.
NCI's reference terminology and related vocabulary resources to help patients, researchers, clinicians, and administrators identify types of cancer, treatments, and other cancer-related topics.